A novel genomic disorder: a deletion of the SACS gene leading to spastic ataxia of Charlevoix-Saguenay

Eur J Hum Genet. 2008 Sep;16(9):1050-4. doi: 10.1038/ejhg.2008.58. Epub 2008 Apr 9.


We report a Belgian patient with early-onset cerebellar ataxia, progressive spasticity, learning difficulties and moderate perceptive hearing loss. Array-Comparative Genomic Hybridisation (aCGH) detected a 1.54 Mb deletion on chromosome 13q12.12. This microdeletion occurred de novo and encompasses the SACS gene. Mutations in SACS are known to cause a recessive condition, similar to the patient's phenotype, called autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Sequencing of the remaining SACS allele revealed a hemizygous mutation c.10517T>C in exon 9, resulting in an amino-acid substitution (p.F3506S). This is the first patient with ARSACS that carries a de novo chromosomal deletion comprising SACS. We demonstrate the presence of homologous segmental duplications at the breakpoint-containing regions. This suggests non-allelic homologous recombination as the mechanism generating this deletion and explains the previous description of copy number variations of this region. This finding confirms the contribution of aCGH to gene identification in autosomal recessive disorders.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cerebellar Ataxia / genetics*
  • Female
  • Gait Ataxia / genetics
  • Gene Deletion*
  • Genes, Recessive
  • Genome, Human*
  • Heat-Shock Proteins / genetics*
  • Humans
  • Infant
  • Male
  • Muscle Spasticity / genetics
  • Nucleic Acid Hybridization
  • Oligonucleotide Array Sequence Analysis
  • Pedigree
  • Point Mutation


  • Heat-Shock Proteins
  • SACS protein, human